🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities! 🎄🌟 🎉
Researchers investigate cancer genomic landscape of Japan
Japan | News | 0 Comment | 17 Feb, 2020
Tokyo Medical and Dental University (TMDU), ACT Genomics (Taipei, Taiwan), and ACTmed (Japan) launched a joint clinical ...Read more
Japan explores muscular dystrophy associated cardiomyopathy
Japan | News | 0 Comment | 14 Feb, 2020
In a study recently published in Nature Communications, scientists at Japan based Okayama University describe ...Read more
Foundation Medicine & Chugai announce partnership with NCC
Japan | News | 0 Comment | 13 Feb, 2020
Foundation Medicine, Inc. and Chugai Pharmaceutical Co., Ltd. have entered into an agreement with the&nbs...Read more
Nippon Shinyaku inks new agreement for prostate cancer treatment
Japan | News | 0 Comment | 12 Feb, 2020
Japan based Nippon Shinyaku Co., LTD. has announced that Janssen Pharmaceutical K.K. and Nippon Shinyaku entered into a ...Read more
Japan suggests combined drug treatment for lung cancer
Japan | News | 0 Comment | 11 Feb, 2020
Researchers at Japan based Kanazawa University report in the Journal of Thoracic Oncology a promising novel ap...Read more
Chugai collaborates with National Cancer Center
Japan | News | 0 Comment | 10 Feb, 2020
Japanese firm Chugai Pharmaceutical Co., Ltd. has announced that it has entered into an agreement with National Cancer C...Read more
Santen, Verily to develop unique ophthalmic devices
Japan | News | 0 Comment | 07 Feb, 2020
Japan based Santen Pharmaceutical Co., Ltd. and US based Verily, an Alphabet company, have announced the establishment o...Read more
Sumitomo Dainippon, Exscientia begin clinical study of AI based OCD drug
Japan | News | 0 Comment | 03 Feb, 2020
Japan based Sumitomo Dainippon Pharma Co., Ltd. and UK based Exscientia Ltd. have announced that a phase I clinical stud...Read more
Japan unveils herbal medicines to treat stomach disorders
Japan | News | 0 Comment | 30 Jan, 2020
In a recent study researchers at Okayama University, Japan illustrate the potential of berberine, a herbal Chinese medic...Read more
Kitakyushu Hospital to initiate Senhance Digital Laparoscopy Program
Japan | News | 0 Comment | 30 Jan, 2020
TransEnterix, Inc. a medical device company that is digitizing the interface between the surgeon and the patient to impr...Read more
AgeX accelerates hypoimmunogenic cells development in Japan
Japan | News | 0 Comment | 31 Jan, 2020
US based AgeX Therapeutics, a biotechnology company developing therapeutics for human aging and regeneration, announced ...Read more
JT to market CORECTIM in Japan to treat atopic dermatitis
Japan | News | 0 Comment | 30 Jan, 2020
Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. (Torii) have announced that JT has received manufacturing and mark...Read more
Eisai and PGDx jointly start R&D of cancer genetics panel test
Japan | News | 0 Comment | 29 Jan, 2020
Japanese firm Eisai Co., Ltd., has entered into a joint research and development agreement with Personal Genome Diagnost...Read more
Eisai’s DAYVIGO gets approval in Japan to treat insomnia
Japan | News | 0 Comment | 28 Jan, 2020
Japanese firm Eisai Co., Ltd has obtained the manufacturing and marketing approval in Japan for its in-house discovered ...Read more
Sasakawa Health Foundation focuses on World Leprosy Day 2020
Japan | News | 0 Comment | 25 Jan, 2020
Sasakawa Health Foundation has announced the start of its first-ever social media campaign with organizations of persons...Read more
Amgen Astellas Biopharma to become wholly owned Amgen affiliate
Japan | News | 0 Comment | 28 Jan, 2020
Amgen, Astellas Pharma and Amgen Astellas BioPharma K.K. announced that on April 1, 2020, Amgen will purchase the 49% of...Read more
Eisai gets approval of anti-epileptic drug in Japan
Japan | News | 0 Comment | 27 Jan, 2020
Japanese firm Eisai Co., Ltd. has obtained the approvals of supplementary new drug applications in Japan for its in-hous...Read more
Japan Ministry approves Propess for cervical ripening
Japan | News | 0 Comment | 23 Jan, 2020
Swiss firm Ferring Pharmaceuticals has announced that Propess® (dinoprostone) has been approved by the Minister...Read more